002437 誉衡药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)4.05517.76012.8867.308-16.527
总资产报酬率 ROA (%)3.02512.6487.7883.330-6.644
投入资产回报率 ROIC (%)3.88016.91210.5484.311-8.525

边际利润分析
销售毛利率 (%)45.57845.34753.46058.38956.925
营业利润率 (%)19.89818.96111.6716.666-8.690
息税前利润/营业总收入 (%)20.01519.16611.5797.924-7.173
净利润/营业总收入 (%)17.93117.9059.9374.901-9.315

收益指标分析
经营活动净收益/利润总额(%)70.21655.96778.23277.354-22.987
价值变动净收益/利润总额(%)16.86734.789-3.077-23.40499.959
营业外收支净额/利润总额(%)-0.1301.149-0.4090.979-0.151

偿债能力分析
流动比率 (X)1.9011.6531.0660.8180.777
速动比率 (X)1.6101.3950.8370.6830.686
资产负债率 (%)23.42626.31930.16745.74958.187
带息债务/全部投入资本 (%)1.3615.0731.62029.48547.661
股东权益/带息债务 (%)7,167.3361,849.4295,981.618234.766107.551
股东权益/负债合计 (%)324.474278.020228.885115.22368.810
利息保障倍数 (X)139.497-1,201.936-264.7006.646-4.769

营运能力分析
应收账款周转天数 (天)21.81621.19924.34629.73726.273
存货周转天数 (天)63.28060.85160.11166.68276.131